Could a Height-Based anesthesia dose prevent dangerous drops in blood pressure?
NCT ID NCT07751835
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This trial tests whether giving spinal anesthesia based on a person's height, rather than a standard fixed dose, can reduce side effects like low blood pressure and slow heart rate during lower limb surgeries. Adults aged 18 to 65 with mild health conditions are eligible to participate. The study compares the two dosing methods to see which one leads to fewer complications.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Height-based dose of hyperbaric bupivacaine 0.5% (spinal anesthetic)
- What this could lead to
- If height-based dosing works, it could make spinal anesthesia safer and more comfortable for patients undergoing lower limb surgeries by reducing side effects like low blood pressure and slow heart rate.
- What could go wrong
- This is an early-phase trial with a small number of participants, so results may not apply to everyone. The height-based dose might not consistently reduce side effects, and there is always a risk of allergic reactions or other anesthesia-related complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1/2
Runs two stages together: safety and dose first, then whether the treatment works.
- Participants
-
About 104 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Aug 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * both genders. 18-65 years age ASA physical status I and II Exclusion Criteria: * ASA III and IV Refusal of patient Height less than 150 cm Known allergy to study drug
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lower limb surgeries are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.